Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M59.7Revenue $M0.1Net Margin (%)--Altman Z-Score-0.4
Enterprise Value $M36.2EPS $-0.1Operating Margin %--Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.9Pre-tax Margin (%)--Higher ROA y-yY
Price/Book3.010-y EBITDA Growth Rate %-4.5Quick Ratio9.3Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %-13.7Current Ratio9.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-51.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-66.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M213ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with RNN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RNNKen Fisher 2014-09-30 Sold Out $0.662 - $0.875
($0.75)
$ 0.28-63%Sold Out0
RNNKen Fisher 2014-06-30 Buy $0.79 - $1.28
($0.95)
$ 0.28-71%New holding10,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RNN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


RNN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Jeong Tae HeumCFO 2015-01-12Sell317,272$0.91-69.23view
Ahn Chang HoDirector 2015-01-12Sell314,656$0.91-69.23view
Ahn Chang HoDirector 2014-06-12Sell136,193$0.99-71.72view
Jeong Tae HeumCFO 2013-09-09Sell71,139$0.46-39.13view
Kivel RichardDirector 2011-10-03Buy2,500$1.04-73.08view
Brandt Peter C.Director 2011-09-09Buy125,000$1.17-76.07view
Brandt Peter C.Director 2011-09-07Buy25,000$0.96-70.83view
Ahn Chang HoChairman & CEO, 10% Owner 2011-05-18Buy1,008,078$1.31-78.63view
Ahn Chang HoChairman & CEO, 10% Owner 2011-04-01Buy320,846$1.22-77.05view
McIntosh David MDirector 2009-07-30Buy5,600$0.8-65view

Quarterly/Annual Reports about RNN:

News about RNN:

Articles On GuruFocus.com
Weekly CEO Buys Highlight: RNN, IIG, FSC, GEO, DAN May 21 2011 
Weekly CEO Buys Highlight: GBDC, EXL, RNN, KYN, CMTL Apr 09 2011 

More From Other Websites
REXAHN PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report May 06 2016
ROTH Capital Partners' Joseph Pantginis Interviewed by The Life Sciences Report Apr 28 2016
Rexahn Pharmaceuticals Presents Clinical Trial Results for Archexin® at the 2016 American... Apr 20 2016
Rexahn Pharmaceuticals Presents Clinical Trial Results for Archexin® at the 2016 American... Apr 20 2016
Rexahn Pharmaceuticals to Present at the 2016 American Association for Cancer Research Annual... Apr 13 2016
Rexahn Pharmaceuticals to Present at the 2016 American Association for Cancer Research Annual... Apr 13 2016
Rexahn Pharmaceuticals Announces Initiation of Phase Ib/IIa Clinical Trial of Its Novel Oral... Mar 29 2016
Rexahn Pharmaceuticals Announces Initiation of Phase Ib/IIa Clinical Trial of Its Novel Oral... Mar 29 2016
Rexahn Pharmaceuticals Presents Additional Data for Supinoxin for the Treatment of Triple Negative... Mar 24 2016
Rexahn Pharmaceuticals Presents Additional Data for Supinoxin for the Treatment of Triple Negative... Mar 24 2016
REXAHN PHARMACEUTICALS, INC. Financials Mar 17 2016
Rexahn reports 4Q loss Mar 14 2016
Rexahn reports 4Q loss Mar 14 2016
Rexahn Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Financial Results Mar 14 2016
REXAHN PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report Mar 14 2016
REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 02 2016
13G Filing: Sabby Capital Opens Large Position in Rexahn Pharmaceuticals, Inc. (RNN) Feb 29 2016
REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Feb 26 2016
Rexahn Announces $5 Million Registered Direct Offering Feb 26 2016
Oral is Better: Rexahn Astounds with New Cancer Data Feb 23 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)